IMO, there has been something wrong with GvHD. Either the dose given wasn’t high enough or the results aren’t what NP expected. Also, GvHD isn’t a common disease so patients may be hard to recruit. NP likes to keep bad news to himself and announces good results even if it’s on 1 patient. I don’t recall NP mentioning news on the patient injected earlier this year or any patient in the past (although I’m not boned up on the GvHD trials).